Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Salt Lake City, UT
NPI: 1649296880Primary Practice Location
UNIVERSITY OF UTAH HOSPITAL AND CLINICS
1950 Circle Of Hope Dr, Salt Lake City, UT
Primary Employer
Huntsman Cancer Hospital Bmt
healthcare.utah.edu
HQ Phone
Get DO Brian's Phone Numberphone_androidMobile
Get DO Brian's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardUT State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 99 | 224 |
| 2 | G0316Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | 19 | 256 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 18 | 92 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 15 | 15 |
| 5 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 14 | 33 |
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.
Authors: Brian Mcclune, Daniel Weisdorf, Tanya Pedersen, Gisela Tunes Da Silva, Martin Tallman, Jorge Sierra, John Dipersio, Armand Keating, Robert Gale, Biju George, Vikas Gupta, Theresa Hahn, Luis Isola, Madan Jagasia, Hillard Lazarus, David Marks, Richard Maziarz, Edmund Waller, Chris Bredeson, Sergio Giralt
Publication Date: 2010-03-10
Authors: Nelli Bejanyan, Hewan Belete, Celalettin Ustun, Veronika Bachanova, Mukta Arora, Daniel Weisdorf
Journal: Am J Hematol
Publication Date: 2017-07-19
Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone.
Authors: Paul Shaughnessy, Anthony Sung
Publication Date: 2013-01-30
Lead Sponsor: Masonic Cancer Center, University of Minnesota
Intervention / Treatment: DRUG: carboplatin, DRUG: paclitaxel, BIOLOGICAL: filgrastim, DRUG: ifosfamide, DRUG: Mesna, DRUG: etoposide, DRUG: thiotepa, PROCEDURE: autologous hematopoietic stem cell transplantation
Lead Sponsor: Masonic Cancer Center, University of Minnesota
Intervention / Treatment: DRUG: Melphalan, PROCEDURE: Stem Cell Transplant, DRUG: Cyclophosphamide + Mesna, BIOLOGICAL: Granulocyte-colony stimulating factor
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Biospecimen Collection, DRUG: Lenalidomide, DRUG: Dexamethasone, DRUG: Carfilzomib, PROCEDURE: Echocardiography, DRUG: Navtemadlin, PROCEDURE: Bone Marrow Aspiration and Biopsy, DRUG: Dexamethasone Sodium Phosphate
